Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
23.93 USD | -2.01% | +13.84% | +164.42% |
Mar. 15 | Avidity Biosciences Insider Sold Shares Worth $980,760, According to a Recent SEC Filing | MT |
Mar. 14 | Cantor Fitzgerald Starts Avidity Biosciences With Overweight Rating, $60 Price Target | MT |
Financials (USD)
Sales 2024 * | 13.46M | Sales 2025 * | 10.5M | Capitalization | 1.91B |
---|---|---|---|---|---|
Net income 2024 * | -274M | Net income 2025 * | -321M | EV / Sales 2024 * | 88.4 x |
Net cash position 2024 * | 722M | Net cash position 2025 * | 431M | EV / Sales 2025 * | 141 x |
P/E ratio 2024 * |
-7.74
x | P/E ratio 2025 * |
-6.81
x | Employees | 253 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 71.74% |
Latest transcript on Avidity Biosciences, Inc.
1 day | -2.01% | ||
1 week | +11.51% | ||
Current month | +30.77% | ||
1 month | +68.76% | ||
3 months | +176.65% | ||
6 months | +241.37% | ||
Current year | +164.42% |
Managers | Title | Age | Since |
---|---|---|---|
Troy Wilson
FOU | Founder | 55 | 12-11-12 |
Sarah Boyce
CEO | Chief Executive Officer | 52 | 19-09-30 |
Michael MacLean
DFI | Director of Finance/CFO | 58 | 20-05-18 |
Members of the board | Title | Age | Since |
---|---|---|---|
Arthur Levin
BRD | Director/Board Member | 70 | 13-09-30 |
Carsten Boess
BRD | Director/Board Member | 57 | 20-04-12 |
Edward Kaye
BRD | Director/Board Member | 75 | 19-08-21 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.11% | 0 M€ | 0.00% | - | |
0.08% | 0 M€ | 0.00% | - | |
0.08% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-03-18 | 23.93 | -2.01% | 1,920,287 |
24-03-15 | 24.42 | +1.88% | 1,683,893 |
24-03-14 | 23.97 | -3.46% | 2,387,284 |
24-03-13 | 24.83 | +9.43% | 1,494,538 |
24-03-12 | 22.69 | +7.94% | 1,220,327 |
Delayed Quote Nasdaq, March 18, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+164.42% | 1.95B | |
-2.64% | 88.93B | |
+13.03% | 44.17B | |
+36.31% | 21.57B | |
-17.46% | 16.89B | |
-13.08% | 15.82B | |
-8.68% | 13.11B | |
-2.24% | 12.56B | |
+0.30% | 8.89B | |
-1.05% | 8.85B |